These results suggested that AB073614 promoted the progression of glioma by activating Wnt/β-catenin signaling through downregulating Sox7, and the inhibition of AB073614 might be a potential therapeutic approach for treating glioma. Here, SOX7 is linked to central nervous system cancer.